U.S. Markets closed

Orgenesis Inc. Provides 2018 Corporate Highlights, Clinical Development and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com

LOS ANGELES, CA / ACCESSWIRE / March 27, 2019 / StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Vered Caplan, CEO of Orgenesis Inc. (ORGS), a developer, manufacturer and service provider of advanced cell therapies, according to the company's website (see here: www.orgenesis.com). The video interview was recorded at the BIO CEO & Investor Conference 2019 in New York, NY.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

Update with Orgenesis Inc. - Provides 2018 Corporate Highlights, Clinical Development and Growth Drivers for 2019

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About Orgenesis

Orgenesis is a biotechnology company specializing in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. The Company operates through two platforms: (i) a point-of-care ("POCare") cell therapy platform ("PT") and (ii) a Contract Development and Manufacturing Organization ("CDMO") platform conducted through its subsidiary, Masthercell Global. Through its PT business, the Company's aim is to further the development of Advanced Therapy Medicinal Products ("ATMPs") through collaborations and in-licensing with other pre-clinical and clinical-stage biopharmaceutical companies and research and healthcare institutes to bring such ATMPs to patients. The Company out-licenses these ATMPs through regional partners to whom it also provides regulatory, pre-clinical and training services to support their activity in order to reach patients in a point-of-care hospital setting. Through the Company's CDMO platform, it is focused on providing contract manufacturing and development services for biopharmaceutical companies. The CDMO platform operates through Masthercell Global, which currently consists of MaSTherCell in Belgium, Atvio in Israel and subsidiaries in South Korea and in the United States, each having unique know-how and expertise for manufacturing in a multitude of cell types. Additional information is available at: www.orgenesis.com.

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.

StockNewsNow.com

info@stocknewsnow.com

SOURCE: StockNewsNow.com



View source version on accesswire.com:
https://www.accesswire.com/540292/Orgenesis-Inc-Provides-2018-Corporate-Highlights-Clinical-Development-and-Growth-Drivers-for-2019-in-New-SNNLive-Video-Interview-on-StockNewsNowcom